You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 129 No. 3, March 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Challenges in Otolaryngology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Oncology
 •Head & Neck Cancer
 •Genetics of Head & Neck Disease
 •Neoplasms of Head & Neck
 •Pathology of Head & Neck
 •Alert me on articles by topic

Genetic Markers of Head and Neck Cancer

Identifying New Molecular Targets

Arch Otolaryngol Head Neck Surg. 2003;129:366-367.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Dr Friedlander has done an elegant and realistic review of the present utility of genetic markers in the clinical care of patients with head and neck cancer. Clearly, no marker for HNSCC has been identified analogous to prostate-specific antigen for prostate cancer. In truth, there is no evidence to date that such a specific marker for head and neck cancer or SCC in general even exists. There are several reasons for this fact. First, biomarker studies are exceedingly complex and require analysis of large homogeneous study populations. Additionally, head and neck cancers are heterogeneous biologically as well as clinicopathologically. For example, different genes may be implicated in tonsil cancer than in larynx cancer, or different genes may be involved in tumors arising in nonsmokers than those in smokers.


 
Figure appears in full text version.
Carol R. Bradford, MD


However, some progress has been made on the front of prognostic markers for outcome in head and neck . . . [Full Text of this Article]


RELATED ARTICLES

The Use of Genetic Markers in the Clinical Care of Patients With Head and Neck Cancer
Paul L. Friedlander
Arch Otolaryngol Head Neck Surg. 2003;129(3):363-366.
EXTRACT | FULL TEXT  

Genetic Markers in the Clinical Care of Head and Neck Cancer: Slow in Coming
Wayne Koch
Arch Otolaryngol Head Neck Surg. 2003;129(3):367-368.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.